human embryonic stem cells-derived neural progenitor cell therapy (Eyestem Research)

N/A

Report date: 2025/06/11 10:26:34

Base Information

Drug Namehuman embryonic stem cells-derived neural progenitor cell therapy (Eyestem Research)
Drug Alias NamehESC-derived NPC therapy (Eyestem Research)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionNeuroprotectants
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEyestem Research Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEyestem Research Pvt Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A